GlaxoSmithKline has in-licensed Janssen’s anti-IL-33R monoclonal antibody for severe asthma. The British...
Up To Date
Latest News
In view of the Brexit, research academies across Britain are calling for a “bold commitment” from the...
Belgian molecular diagnostics company Biocartis Group NV has raised €55m and will use the funds mainly to...
Europe’s first gene therapy company has floated on Euronext: Gensight raised €40m in its IPO. And it is not...
When NASA blasted off to the International Space Station on Monday morning, it had UK tech on board. A...
Cell Medica has acquired Swiss antibody specialist Delenex Therapeutics. The deal nets the British cellular...